4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-12-039994
Executive VP, R&D acquired 210,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shaaltiel Yoseph Executive VP, R&D | 2012-07-16 | Grant or award | +210,000 | 210,000 | I |
Loading xslF345X03/v318896_4.xml…